• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • #innov8aid

    New grant for child survival innovations

    Can you think of a simple, effective, replicable and scalable approach to reducing infant mortality? Then Save the Children and GlaxoSmithKline want to hear from you.

    By Jenny Lei Ravelo // 26 June 2013
    A baby receives oral vaccination. Save the Children and GlaxoSmithKline are looking for simple, effective, replicable and scalable innovations to reducing infant mortality. Photo by: Save the Children UK

    The care of preterm infants often described as “kangaroo mother care” — which involves skin-to-skin contact with the baby — has helped trim down the number of preventable child deaths since 1990 from 12 million to 6.9 million, according to global health experts.

    Can you think of a simple, effective, replicable and scalable approach to reducing infant mortality?

    As part of a new 5-year partnership announced in May, Save the Children and pharmaceutical giant GlaxoSmithKline are looking for innovative interventions or practices in developing countries that have shown tangible results in helping improve child survival rates. It can be an idea, tool, delivery mechanism or a business model carried out by a nonprofit, academic institution, health care facility or government-funded institutions, such as universities and think tanks.

    Only those based in low- and middle-income countries as per the World Bank’s classification are eligible for the award. But international organizations with offices or work in those countries can apply. Local organizations with partners based in high-income countries are also welcome to participate.

    Individuals can nominate innovations by a particular organization. But only “the organization which developed or is practicing the innovation will receive [the] award funding,” a spokesperson for Save the Children U.K. told Devex.

    Judges, which include Joe Cerrell, director of the Bill & Melinda Gates Foundation Europe office, and Nigel Crisp, an independent member of the U.K. House of Lords and prominent public health advocate, will evaluate the applications based on the following criteria:

    • How innovative and transformative is it?

    • To what extent is it being used?

    • What is its long-term impact and how sustainable is it?

    • How can it be replicated in other locations?

    • How will the award money be spent?

    Interested parties can submit more than one idea or approach; organizations working on a similar project can jointly apply. Projects should have proven results for at least two years.

    The deadline for submissions is Aug. 26. Winners will be announced in November; the grand prize is worth $250,000 while runners-up will share a $750,000 cash prize.

    “It will be divided as per the judging panel’s decision depending on how much they feel each application or innovation warrants, or needs for a specific purpose,” the spokesperson explained, adding GSK and Save the Children may provide other forms of assistance, “depending on the application.”

    The award aims to showcase interventions that work, and help other organizations tackling under-five mortality find and adapt successful and proven ones in the field.

    Read our last #innov8aid.

    • Funding
    • Institutional Development
    • Innovation & ICT
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Jenny Lei Ravelo

      Jenny Lei Ravelo@JennyLeiRavelo

      Jenny Lei Ravelo is a Devex Senior Reporter based in Manila. She covers global health, with a particular focus on the World Health Organization, and other development and humanitarian aid trends in Asia Pacific. Prior to Devex, she wrote for ABS-CBN, one of the largest broadcasting networks in the Philippines, and was a copy editor for various international scientific journals. She received her journalism degree from the University of Santo Tomas.

    Search for articles

    Related Stories

    INGOsOpinion: As a CEO at an INGO, I know we need to adapt or die

    Opinion: As a CEO at an INGO, I know we need to adapt or die

    Global HealthRobert F. Kennedy Jr. says the US is cutting funding for Gavi

    Robert F. Kennedy Jr. says the US is cutting funding for Gavi

    The Trump Effect‘The system is breaking’: US aid freeze threatens child malnutrition care

    ‘The system is breaking’: US aid freeze threatens child malnutrition care

    Global Health‘Disaster’ as health programs reel from USAID terminations

    ‘Disaster’ as health programs reel from USAID terminations

    Most Read

    • 1
      How low-emissions livestock are transforming dairy farming in Africa
    • 2
      Opinion: Mobile credit, savings, and insurance can drive financial health
    • 3
      Opinion: India’s bold leadership in turning the tide for TB
    • 4
      How AI-powered citizen science can be a catalyst for the SDGs
    • 5
      Strengthening health systems by measuring what really matters
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement